Reports world wide Polycystic Ovary Syndrome (PCOS) | Página 2

6
7
8
9
Anti-diabetic agents
Aromatase inhibitors
Anti-androgens
Oral contraceptive pills
10 EPIDEMIOLOGY
11 MARKETED DRUGS
12 Approvals by country
13 PIPELINE DRUGS
14 LICENSING AND ASSET ACQUISITION DEALS
15 PARENT PATENTS
16 CLINICAL TRIAL LANDSCAPE
17 Sponsors by status
18 Sponsors by phase
19 BIBLIOGRAPHY
20 Prescription information:
21 APPENDIX
LIST OF FIGURES
Figure 1: Trends in prevalent cases of PCOS (Rotterdam Criteria), 2016–25
Figure 2: Trends in prevalent cases of PCOS (NIH Criteria), 2016–25
Figure 3: Pipeline drugs for PCOS in the US
Figure 4: Pipeline drugs for PCOS, by company
Figure 5: Pipeline drugs for PCOS, by drug type
Figure 6: Pipeline drugs for PCOS, by drug classification
Figure 7: Licensing and asset acquisition deals in PCOS
Figure 8: Parent patents in PCOS
Figure 9: Clinical trials in PCOS
Figure 10: Top 10 drugs for clinical trials in PCOS
Figure 11: Top 10 companies for clinical trials in PCOS
Figure 12: Trial locations in PCOS
Figure 13: PCOS trials sponsors, by status
Figure 14: PCOS trials sponsors, by phase
LIST OF TABLES
Table 1: Prevalent cases of PCOS (Rotterdam Criteria), 2016–25
Table 2: Prevalent cases of PCOS (NIH Criteria), 2016–25
Table 3: Marketed drugs for PCOS
Table 4: Approvals by country for PCOS
Table 5: Pipeline drugs for PCOS in the US
Ask to Expertise @
https://www.reportsworldwide.com/enquiry?report_id=42615
About US:
Reportsworldwide.com is a one stop shop for all market intelligence needs. Our database of
market research reports provides in depth coverage of 12 top industry verticals worldwide.